Interaction databaseSupplement × PrescriptionReviewed May 2026

L-Lysine and Valacyclovir, a synergy.

Valacyclovir is the prodrug of acyclovir, and L-lysine prophylaxis works through a separate, arginine-competition mechanism against HSV. Evidence is modest and best supported for daily doses above 1 g, but there is no known pharmacokinetic interaction with valacyclovir, and combination use is reasonable for recurrence prevention.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
L-Lysine and Valacyclovir
Pair type
Synergy
Evidence (highest tier)
Emerging
Source citations
2 sources
Stack Score effect
+2 to your Stack Score (per scored synergy row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Synergy · Emerging evidence

Synergy

What is happening. Valacyclovir is the prodrug of acyclovir, and L-lysine prophylaxis works through a separate, arginine-competition mechanism against HSV. Evidence is modest and best supported for daily doses above 1 g, but there is no known pharmacokinetic interaction with valacyclovir, and combination use is reasonable for recurrence prevention.

Mechanism. Lysine competes with arginine, which HSV requires for capsid protein synthesis. Valacyclovir is converted to acyclovir, which inhibits viral DNA polymerase. The mechanisms do not overlap or interfere.

Recommendation. Lysine 1-3 g/day is a reasonable adjunct to valacyclovir for recurrent HSV. Continue valacyclovir as prescribed during active outbreaks; do not rely on lysine alone.

Sources (2)
  1. Mailoo VJ, Rampes S. Lysine for herpes simplex prophylaxis: a review of the evidence. Integr Med (Encinitas). 2017;16(3):42-46. PMID 30881246
  2. Griffith RS, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica. 1987;175(4):183-90. PMID 3115841

Stack Score

How this pair moves the number.

Effect on the composite score

If both L-Lysine and Valacyclovir are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.